Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 9;115(2):361-366.
doi: 10.1073/pnas.1715788115. Epub 2017 Dec 26.

Field- and clinically derived estimates of Wolbachia-mediated blocking of dengue virus transmission potential in Aedes aegypti mosquitoes

Affiliations

Field- and clinically derived estimates of Wolbachia-mediated blocking of dengue virus transmission potential in Aedes aegypti mosquitoes

Lauren B Carrington et al. Proc Natl Acad Sci U S A. .

Abstract

The wMel strain of Wolbachia can reduce the permissiveness of Aedes aegypti mosquitoes to disseminated arboviral infections. Here, we report that wMel-infected Ae. aegypti (Ho Chi Minh City background), when directly blood-fed on 141 viremic dengue patients, have lower dengue virus (DENV) transmission potential and have a longer extrinsic incubation period than their wild-type counterparts. The wMel-infected mosquitoes that are field-reared have even greater relative resistance to DENV infection when fed on patient-derived viremic blood meals. This is explained by an increased susceptibility of field-reared wild-type mosquitoes to infection than laboratory-reared counterparts. Collectively, these field- and clinically relevant findings support the continued careful field-testing of wMel introgression for the biocontrol of Ae. aegypti-born arboviruses.

Keywords: Aedes aegypti mosquito; dengue virus; extrinsic incubation period; virus transmission; wMel Wolbachia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Proportion of mosquitoes with infectious virus in their saliva, as a function of log10 plasma viremia (RNA copies per milliliter). Within each panel, the scatterplots and corresponding smooth curves based on logistic regression are shown, with panels separating virus serotypes. Data points represent the proportion of mosquitoes in a given unique cohort of WT or wMel mosquitoes that had infectious saliva on the day of harvesting. Data are pooled from day 10, 12, 14, and 16 harvesting time points. The size of the dot indicates the number of mosquitoes in that cohort.
Fig. 2.
Fig. 2.
Predicted probability of mosquitoes with DENV-positive saliva for WT and wMel Ae. aegypti mosquitoes, based on a marginal logistic regression model. Each dot point shows the proportion of all mosquitoes that had DENV in their saliva among all mosquitoes that took a blood meal. The corresponding smoothing curves and shading (representing 95% CIs) illustrate the predicted probability of having virus in saliva between days 8 and 20 postexposure to DENV-1 and DENV-4 serotypes (DENV-2 and DENV-3 were excluded due to the small numbers of patients infected with these serotypes).
Fig. 3.
Fig. 3.
Outcomes of field- and laboratory-rearing vector competence experiments for WT and wMel-infected Aedes aegypti. (A) Proportion of field- and laboratory-reared WT and wMel-infected mosquitoes with infectious saliva after indirect feeding on viremic human blood, as a function of log10 plasma viremia (RNA copies per milliliter). Data are stratified by rearing conditions and the serotype to which the mosquitoes were exposed. Data points represent cohorts of mosquitoes exposed to a single patient blood meal; the size of the dot indicates the mosquito cohort size. (B) wMel-mediated percentage reduction in mosquitoes with infectious saliva, under field- and laboratory-rearing conditions. The boxplot depicts the percentage reductions (medians and interquartile range) in DENV infection rates in saliva, between paired WT/wMel-infected mosquito cohorts (the number of pairs within a group, indicated along the axis). Positive estimates indicate that Wolbachia reduced the relative infection rate; negative estimates indicate a paired cohort had higher infection rates in Wolbachia-infected mosquitoes compared with WT females. Note: DENV-3 is excluded due to small sample sizes.

References

    1. Sabchareon A, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial. Lancet. 2012;380:1559–1567. - PubMed
    1. Hadinegoro SR, et al. CYD-TDV Dengue Vaccine Working Group Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;373:1195–1206. - PubMed
    1. Olivera-Botello G, et al. CYD-TDV Vaccine Trial Group Tetravalent dengue vaccine reduces symptomatic and asymptomatic dengue virus infections in healthy children and adolescents aged 2-16 years in Asia and Latin America. J Infect Dis. 2016;214:994–1000. - PMC - PubMed
    1. Ferguson NM, et al. Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment. Science. 2016;353:1033–1036. - PMC - PubMed
    1. Mitchell-Foster K, et al. The influence of larval density, food stress, and parasitism on the bionomics of the dengue vector Aedes aegypti (Diptera: Culicidae): Implications for integrated vector management. J Vector Ecol. 2012;37:221–229. - PubMed

Publication types